In our mouse model of mutant Mll3, loss of catalytic function alone was not sufficient to drive malignancy (S6 Fig), even though loss of MLL3 due to chromosome 7 aberrations is associated with increased risk of AML development and poor prognosis [4, 11]. The gene discussed is KMT2C; the disease is acute myeloid leukemia.